Zimmer Biomet Holdings Inc. will pay $30.5m to settle allegations that the company’s actions in Mexico and Brazil violated the Foreign Corrupt Practices Act (FCPA), the US Department of Justice announced Jan. 12.
The payments stem from allegations that Biomet Inc. paid bribes to Mexican government officials and violated the FCPA’s internal controls provision in Mexico and Brazil. In addition, the company’s actions breached a 2012 deferred prosecution agreement between the Department of Justice and Biomet. The agreement had been set to expire in 2015, but DOJ extended it based on allegations of ongoing misconduct
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?